Turn Therapeutics (TTRX) Intangibles (2024 - 2026)

Turn Therapeutics (TTRX) posted quarterly Intangibles of $919947.0 for Q1 2026, little changed quarter-over-quarter from $922171.0 in Q4 2025.

Turn Therapeutics (TTRX) Intangibles (2024 - 2026) Analysis & Trends

Turn Therapeutics' Intangibles history runs 3 years deep, the most recent figure standing at $919947.0 for Q1 2026.

In Q1 2026, Intangibles changed N/A year-over-year to $919947.0; the TTM figure through Mar 2026 stood at $919947.0 (changed N/A YoY), while the FY2025 annual figure was $922171.0, up 12.2% from the prior year.
Intangibles for Q1 2026 stood at $919947.0, roughly flat from $922171.0 in the prior quarter.
The five-year high for Intangibles was $922171.0 in Q4 2025, with the low at $821931.0 in Q4 2024.
The 3-year median for Intangibles is $912416.0 (2025), against an average of $892233.5.
Peak annual rise in Intangibles reached 12.2% in 2025, while the deepest fall reached 12.2% in 2025.
Turn Therapeutics' Intangibles stood at $821931.0 in 2024, then advanced by 12.2% to $922171.0 in 2025, then dropped by 0.24% to $919947.0 in 2026.
Business Quant data shows TTRX's Intangibles at $919947.0 in Q1 2026, $922171.0 in Q4 2025, and $904885.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Intangibles (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	412.80 Mn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.31 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	266.00 Mn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	63.28 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	60.96 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	-
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	93.49 Mn
10	Turn Therapeutics	285.07 Mn	285.07 Mn	-	911,219.00

Download Data